Macrophage induced ERK-TGF-β1 signaling in MCF7 breast cancer cells result in reversible cancer stem cell plasticity and epithelial mesenchymal transition
Breast cancer is a heterogenous disease composed of multiple clonal populations and the mechanism by which the tumor microenvironment induces cancer stem cell plasticity is not fully understood.BACKGROUNDBreast cancer is a heterogenous disease composed of multiple clonal populations and the mechanis...
Saved in:
Published in | Biochimica et biophysica acta. General subjects Vol. 1866; no. 11; p. 130215 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
01.11.2022
|
Subjects | |
Online Access | Get full text |
ISSN | 0304-4165 1872-8006 1872-8006 |
DOI | 10.1016/j.bbagen.2022.130215 |
Cover
Abstract | Breast cancer is a heterogenous disease composed of multiple clonal populations and the mechanism by which the tumor microenvironment induces cancer stem cell plasticity is not fully understood.BACKGROUNDBreast cancer is a heterogenous disease composed of multiple clonal populations and the mechanism by which the tumor microenvironment induces cancer stem cell plasticity is not fully understood.MCF7 breast cancer cells were treated with macrophage conditioned medium (MɸCM). PD98059 and SB431542 were used for ERK and TGF-βR inhibition respectively. Epithelial-mesenchymal transition (EMT) and cancer stem cell markers (CSC) were studied using qRT-PCR and flowcytometry. SCID mice were used for animal experiments.METHODSMCF7 breast cancer cells were treated with macrophage conditioned medium (MɸCM). PD98059 and SB431542 were used for ERK and TGF-βR inhibition respectively. Epithelial-mesenchymal transition (EMT) and cancer stem cell markers (CSC) were studied using qRT-PCR and flowcytometry. SCID mice were used for animal experiments.MɸCM- induced ERK/TGF-β1 signaling led to enrichment of CSC and EMT in MCF7 cells and mammospheres. These effects were abrogated by both MEK inhibitor PD98059 (TGF-β1 synthesis) and SB431542 (TGF-β1 signaling). The increase in CSC was both hybrid (ALDH1+) and mesenchymal (CD44+ CD24- cells). Increase in hybrid E/M state was at a single cell level as confirmed by the increase in both claudin-1 (E) and vimentin (M). This did not have any growth advantage in SCID mice and monitoring of CSC and EMT markers before and after growth in SCID mice indicated reversal of these markers in tumor cells recovered from mice. Removal of MɸCM and neutralization of TNF-α, IL-6 and IL-1β in MɸCM abrogated ERK phosphorylation, TGF-β and CSC enrichment indicating the requirement of continuous signaling for maintenance.RESULTSMɸCM- induced ERK/TGF-β1 signaling led to enrichment of CSC and EMT in MCF7 cells and mammospheres. These effects were abrogated by both MEK inhibitor PD98059 (TGF-β1 synthesis) and SB431542 (TGF-β1 signaling). The increase in CSC was both hybrid (ALDH1+) and mesenchymal (CD44+ CD24- cells). Increase in hybrid E/M state was at a single cell level as confirmed by the increase in both claudin-1 (E) and vimentin (M). This did not have any growth advantage in SCID mice and monitoring of CSC and EMT markers before and after growth in SCID mice indicated reversal of these markers in tumor cells recovered from mice. Removal of MɸCM and neutralization of TNF-α, IL-6 and IL-1β in MɸCM abrogated ERK phosphorylation, TGF-β and CSC enrichment indicating the requirement of continuous signaling for maintenance.ERK signaling plays an important role in MɸCM- induced EMT and CSC plasticity which is completely reversible upon withdrawal of signals.CONCLUSIONSERK signaling plays an important role in MɸCM- induced EMT and CSC plasticity which is completely reversible upon withdrawal of signals.Our experimental observations support the semi-independent nature of EMT-stemness connection which is very dynamic and reversible depending on the microenvironment.GENERAL SIGNIFICANCEOur experimental observations support the semi-independent nature of EMT-stemness connection which is very dynamic and reversible depending on the microenvironment. |
---|---|
AbstractList | Breast cancer is a heterogenous disease composed of multiple clonal populations and the mechanism by which the tumor microenvironment induces cancer stem cell plasticity is not fully understood. MCF7 breast cancer cells were treated with macrophage conditioned medium (MɸCM). PD98059 and SB431542 were used for ERK and TGF-βR inhibition respectively. Epithelial-mesenchymal transition (EMT) and cancer stem cell markers (CSC) were studied using qRT-PCR and flowcytometry. SCID mice were used for animal experiments. MɸCM- induced ERK/TGF-β1 signaling led to enrichment of CSC and EMT in MCF7 cells and mammospheres. These effects were abrogated by both MEK inhibitor PD98059 (TGF-β1 synthesis) and SB431542 (TGF-β1 signaling). The increase in CSC was both hybrid (ALDH1⁺) and mesenchymal (CD44⁺ CD24⁻ cells). Increase in hybrid E/M state was at a single cell level as confirmed by the increase in both claudin-1 (E) and vimentin (M). This did not have any growth advantage in SCID mice and monitoring of CSC and EMT markers before and after growth in SCID mice indicated reversal of these markers in tumor cells recovered from mice. Removal of MɸCM and neutralization of TNF-α, IL-6 and IL-1β in MɸCM abrogated ERK phosphorylation, TGF-β and CSC enrichment indicating the requirement of continuous signaling for maintenance. ERK signaling plays an important role in MɸCM- induced EMT and CSC plasticity which is completely reversible upon withdrawal of signals. Our experimental observations support the semi-independent nature of EMT-stemness connection which is very dynamic and reversible depending on the microenvironment. Breast cancer is a heterogenous disease composed of multiple clonal populations and the mechanism by which the tumor microenvironment induces cancer stem cell plasticity is not fully understood.BACKGROUNDBreast cancer is a heterogenous disease composed of multiple clonal populations and the mechanism by which the tumor microenvironment induces cancer stem cell plasticity is not fully understood.MCF7 breast cancer cells were treated with macrophage conditioned medium (MɸCM). PD98059 and SB431542 were used for ERK and TGF-βR inhibition respectively. Epithelial-mesenchymal transition (EMT) and cancer stem cell markers (CSC) were studied using qRT-PCR and flowcytometry. SCID mice were used for animal experiments.METHODSMCF7 breast cancer cells were treated with macrophage conditioned medium (MɸCM). PD98059 and SB431542 were used for ERK and TGF-βR inhibition respectively. Epithelial-mesenchymal transition (EMT) and cancer stem cell markers (CSC) were studied using qRT-PCR and flowcytometry. SCID mice were used for animal experiments.MɸCM- induced ERK/TGF-β1 signaling led to enrichment of CSC and EMT in MCF7 cells and mammospheres. These effects were abrogated by both MEK inhibitor PD98059 (TGF-β1 synthesis) and SB431542 (TGF-β1 signaling). The increase in CSC was both hybrid (ALDH1+) and mesenchymal (CD44+ CD24- cells). Increase in hybrid E/M state was at a single cell level as confirmed by the increase in both claudin-1 (E) and vimentin (M). This did not have any growth advantage in SCID mice and monitoring of CSC and EMT markers before and after growth in SCID mice indicated reversal of these markers in tumor cells recovered from mice. Removal of MɸCM and neutralization of TNF-α, IL-6 and IL-1β in MɸCM abrogated ERK phosphorylation, TGF-β and CSC enrichment indicating the requirement of continuous signaling for maintenance.RESULTSMɸCM- induced ERK/TGF-β1 signaling led to enrichment of CSC and EMT in MCF7 cells and mammospheres. These effects were abrogated by both MEK inhibitor PD98059 (TGF-β1 synthesis) and SB431542 (TGF-β1 signaling). The increase in CSC was both hybrid (ALDH1+) and mesenchymal (CD44+ CD24- cells). Increase in hybrid E/M state was at a single cell level as confirmed by the increase in both claudin-1 (E) and vimentin (M). This did not have any growth advantage in SCID mice and monitoring of CSC and EMT markers before and after growth in SCID mice indicated reversal of these markers in tumor cells recovered from mice. Removal of MɸCM and neutralization of TNF-α, IL-6 and IL-1β in MɸCM abrogated ERK phosphorylation, TGF-β and CSC enrichment indicating the requirement of continuous signaling for maintenance.ERK signaling plays an important role in MɸCM- induced EMT and CSC plasticity which is completely reversible upon withdrawal of signals.CONCLUSIONSERK signaling plays an important role in MɸCM- induced EMT and CSC plasticity which is completely reversible upon withdrawal of signals.Our experimental observations support the semi-independent nature of EMT-stemness connection which is very dynamic and reversible depending on the microenvironment.GENERAL SIGNIFICANCEOur experimental observations support the semi-independent nature of EMT-stemness connection which is very dynamic and reversible depending on the microenvironment. |
ArticleNumber | 130215 |
Author | Kundu, Priya Shankar, Bhavani S. |
Author_xml | – sequence: 1 givenname: Priya surname: Kundu fullname: Kundu, Priya – sequence: 2 givenname: Bhavani S. surname: Shankar fullname: Shankar, Bhavani S. |
BookMark | eNqFkUGOFCEUhokZE3vGuYELlm6qBaqAKnemMz0aZzLJZGZNgHrVTYeiSqBN-izewoN4JilbNy6UhPAI3__g579EF2EKgNAbStaUUPHusDZG7yCsGWFsTWvCKH-BVrSVrGoJERdoRWrSVA0V_BW6TOlAyuAdX6Fv99rGad4XOXahP1ro8c3j5-rpdlv9-E5xcrugvQu7corvN1uJTQSdMrY6WIjYgvcJR0hHnxckwleIyRkPf4iUYfyF4dkXobMun7AOPYbZ5T14pz0eIUGw-9NY6hx1SC67KbxGLwftE1z_Xq_Q8_bmafOxunu4_bT5cFdZ1shc2dZQOwhjiO2EFLzsRCcYL5OxprdSMt6YjnV9w6kw7UB0O1CQlAy16HVdX6G3575znL4cIWU1urS8WAeYjkkxSdu66Urr_6Pl5pZ3su0K-v6Mlv9NKcKginO9-CoOnVeUqCU8dVDn8NQSnjqHV8TNX-I5ulHH079lPwFwM6Rk |
CitedBy_id | crossref_primary_10_1002_jcp_31278 crossref_primary_10_1016_j_jtos_2024_08_014 crossref_primary_10_1038_s41392_024_01851_y crossref_primary_10_31083_j_fbl2809230 crossref_primary_10_3389_fcell_2023_1221175 crossref_primary_10_47248_chp2502010004 |
Cites_doi | 10.1002/path.2793 10.1007/s12079-019-00508-8 10.3892/or.2017.5955 10.1016/j.stemcr.2015.12.006 10.1053/j.gastro.2014.08.039 10.1016/j.biopha.2018.12.055 10.3390/cancers12123765 10.1038/onc.2015.133 10.1038/s41598-019-57285-y 10.1002/cbin.11525 10.1158/0008-5472.CAN-10-2638 10.1073/pnas.1102454108 10.1016/j.cellsig.2014.03.028 10.1038/s41598-018-27021-z 10.1038/onc.2010.546 10.1158/0008-5472.CAN-18-3962 10.1155/2019/7683817 10.1073/pnas.1815345116 10.1165/rcmb.2004-0288OC 10.1155/2019/3904645 10.1016/j.molonc.2015.10.002 10.1016/j.stemcr.2018.03.001 10.1158/2159-8290.CD-19-0015 10.1073/pnas.1812876116 10.1088/1478-3975/ab34df 10.1016/j.canlet.2014.05.008 10.18632/oncotarget.24917 10.1007/s10585-021-10139-2 10.18632/oncotarget.21068 10.1038/srep24606 10.1038/ncomms2039 10.1038/s41598-017-14364-2 10.3390/ijms20112767 10.1016/j.bpj.2013.07.011 10.18632/oncotarget.16624 10.1101/cshperspect.a022301 10.1158/1940-6207.CAPR-10-0234 10.1073/pnas.1018898108 10.1126/scisignal.aau8544 10.1586/erm.12.117 10.1038/srep29479 10.1126/science.959840 10.1186/s10020-021-00383-3 10.1155/2016/1740936 10.1593/neo.04241 |
ContentType | Journal Article |
Copyright | Copyright © 2022 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: Copyright © 2022 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION 7X8 7S9 L.6 |
DOI | 10.1016/j.bbagen.2022.130215 |
DatabaseName | CrossRef MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitle | CrossRef MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | AGRICOLA MEDLINE - Academic |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Biology |
EISSN | 1872-8006 |
ExternalDocumentID | 10_1016_j_bbagen_2022_130215 |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AAEDT AAEDW AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO AAYXX ABEFU ABFNM ABGSF ABMAC ABUDA ABWVN ABXDB ACDAQ ACIUM ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADUVX AEBSH AEHWI AEIPS AEKER AEUPX AFJKZ AFPUW AFTJW AFXIZ AGCQF AGHFR AGQPQ AGRDE AGRNS AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CITATION CS3 EBS EFJIC EJD EO8 EO9 EP2 EP3 FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HLW HVGLF HZ~ IHE J1W KOM LX3 M41 MO0 N9A O-L O9- OAUVE OHT OZT P-8 P-9 PC. Q38 R2- ROL RPZ SBG SCC SDF SDG SDP SES SEW SPCBC SSH SSU SSZ T5K UQL WH7 WUQ XJT XPP ~G- 7X8 EFKBS EFLBG 7S9 L.6 |
ID | FETCH-LOGICAL-c247t-c8b1cf6bb0c96765b1c69625962224dc77254b929d4516b8f0a8f1e710f36da33 |
ISSN | 0304-4165 1872-8006 |
IngestDate | Thu Sep 04 17:14:37 EDT 2025 Fri Sep 05 09:52:38 EDT 2025 Tue Jul 01 00:22:17 EDT 2025 Thu Apr 24 23:06:36 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c247t-c8b1cf6bb0c96765b1c69625962224dc77254b929d4516b8f0a8f1e710f36da33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PQID | 2696859789 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2718349765 proquest_miscellaneous_2696859789 crossref_citationtrail_10_1016_j_bbagen_2022_130215 crossref_primary_10_1016_j_bbagen_2022_130215 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-11-00 20221101 |
PublicationDateYYYYMMDD | 2022-11-01 |
PublicationDate_xml | – month: 11 year: 2022 text: 2022-11-00 |
PublicationDecade | 2020 |
PublicationTitle | Biochimica et biophysica acta. General subjects |
PublicationYear | 2022 |
References | Wan (10.1016/j.bbagen.2022.130215_bb0165) 2014; 147 Iliopoulos (10.1016/j.bbagen.2022.130215_bb0160) 2011; 108 Bruna (10.1016/j.bbagen.2022.130215_bb0170) 2012; 3 Jia (10.1016/j.bbagen.2022.130215_bb0205) 2019; 16 Xie (10.1016/j.bbagen.2022.130215_bb0080) 2004; 6 Chen (10.1016/j.bbagen.2022.130215_bb0235) 2016; 2016 Hojo (10.1016/j.bbagen.2022.130215_bb0045) 2018; 8 Bednarczyk (10.1016/j.bbagen.2022.130215_bb0095) 2018; 9 Colacino (10.1016/j.bbagen.2022.130215_bb0115) 2018; 10 Michor (10.1016/j.bbagen.2022.130215_bb0225) 2010; 3 Vassalli (10.1016/j.bbagen.2022.130215_bb0070) 2019; 2019 Chiou (10.1016/j.bbagen.2022.130215_bb0055) 2010; 70 Chaffer (10.1016/j.bbagen.2022.130215_bb0005) 2011; 108 Hao (10.1016/j.bbagen.2022.130215_bb0145) 2019; 20 Yadav (10.1016/j.bbagen.2022.130215_bb0075) 2021; 45 Hinshaw (10.1016/j.bbagen.2022.130215_bb0010) 2019; 79 Singh (10.1016/j.bbagen.2022.130215_bb0015) 1862; 2018 Li (10.1016/j.bbagen.2022.130215_bb0105) 2017; 7 Zhang (10.1016/j.bbagen.2022.130215_bb0065) 2020; 12 Saadin (10.1016/j.bbagen.2022.130215_bb0135) 2013; 13 Katsuno (10.1016/j.bbagen.2022.130215_bb0185) 2019; 12 Singh (10.1016/j.bbagen.2022.130215_bb0035) 2014; 26 Allavena (10.1016/j.bbagen.2022.130215_bb0100) 2021; 27 Wang (10.1016/j.bbagen.2022.130215_bb0050) 2016; 6 Ruiz (10.1016/j.bbagen.2022.130215_bb0130) 2019; 2019 Yuan (10.1016/j.bbagen.2022.130215_bb0085) 2019; 9 Stylianou (10.1016/j.bbagen.2022.130215_bb0020) 1862; 2018 Andriani (10.1016/j.bbagen.2022.130215_bb0230) 2016; 10 Bocci (10.1016/j.bbagen.2022.130215_bb0110) 2019; 116 Sullivan (10.1016/j.bbagen.2022.130215_bb0195) 2005; 32 Akhurst (10.1016/j.bbagen.2022.130215_bb0240) 2017; 9 Alison (10.1016/j.bbagen.2022.130215_bb0040) 2011; 223 Liang (10.1016/j.bbagen.2022.130215_bb0180) 2016; 6 Kröger (10.1016/j.bbagen.2022.130215_bb0120) 2019; 116 Ehata (10.1016/j.bbagen.2022.130215_bb0175) 2011; 30 Zhang (10.1016/j.bbagen.2022.130215_bb0025) 2017; 8 Fan (10.1016/j.bbagen.2022.130215_bb0030) 2014; 352 Li (10.1016/j.bbagen.2022.130215_bb0190) 2020; 10 Tian (10.1016/j.bbagen.2022.130215_bb0200) 2013; 105 Yadav (10.1016/j.bbagen.2022.130215_bb0060) 2019; 111 Akrap (10.1016/j.bbagen.2022.130215_bb0140) 2016; 6 Sahoo (10.1016/j.bbagen.2022.130215_bb0125) 2022; 39 Gao (10.1016/j.bbagen.2022.130215_bb0090) 2018; 40 Pang (10.1016/j.bbagen.2022.130215_bb0150) 2016; 35 Nowell (10.1016/j.bbagen.2022.130215_bb0220) 1976; 194 Liao (10.1016/j.bbagen.2022.130215_bb0155) 2019; 13 Li (10.1016/j.bbagen.2022.130215_bb0210) 2017; 8 Zhao (10.1016/j.bbagen.2022.130215_bb0215) 2017; 38 |
References_xml | – volume: 223 start-page: 147 year: 2011 ident: 10.1016/j.bbagen.2022.130215_bb0040 article-title: Cancer stem cells: problems for therapy? publication-title: J. Pathol. doi: 10.1002/path.2793 – volume: 13 start-page: 369 year: 2019 ident: 10.1016/j.bbagen.2022.130215_bb0155 article-title: TGF-β1 and TNF-α synergistically induce epithelial to mesenchymal transition of breast cancer cells by enhancing TAK1 activation publication-title: J. Cell Commun. Signal. doi: 10.1007/s12079-019-00508-8 – volume: 38 start-page: 3055 year: 2017 ident: 10.1016/j.bbagen.2022.130215_bb0215 article-title: MEK inhibitor, PD98059, promotes breast cancer cell migration by inducing β-catenin nuclear accumulation publication-title: Oncol. Rep. doi: 10.3892/or.2017.5955 – volume: 2018 start-page: 669 year: 1862 ident: 10.1016/j.bbagen.2022.130215_bb0015 article-title: Significant alterations of the novel 15 gene signature identified from macrophage-tumor interactions in breast cancer publication-title: Biochim. Biophys. Acta Gen. Subj. – volume: 6 start-page: 121 year: 2016 ident: 10.1016/j.bbagen.2022.130215_bb0140 article-title: Identification of distinct breast cancer stem cell populations based on single-cell analyses of functionally enriched stem and progenitor pools publication-title: Stem Cell Rep. doi: 10.1016/j.stemcr.2015.12.006 – volume: 147 start-page: 1393 year: 2014 ident: 10.1016/j.bbagen.2022.130215_bb0165 article-title: Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells publication-title: Gastroenterology doi: 10.1053/j.gastro.2014.08.039 – volume: 111 start-page: 119 year: 2019 ident: 10.1016/j.bbagen.2022.130215_bb0060 article-title: Radio resistance in breast cancer cells is mediated through TGF-β signalling, hybrid epithelial-mesenchymal phenotype and cancer stem cells publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2018.12.055 – volume: 12 year: 2020 ident: 10.1016/j.bbagen.2022.130215_bb0065 article-title: Breast cancer stem cells: biomarkers, identification and isolation methods, regulating mechanisms, cellular origin, and beyond publication-title: Cancers (Basel) doi: 10.3390/cancers12123765 – volume: 35 start-page: 748 year: 2016 ident: 10.1016/j.bbagen.2022.130215_bb0150 article-title: TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis publication-title: Oncogene doi: 10.1038/onc.2015.133 – volume: 10 start-page: 377 year: 2020 ident: 10.1016/j.bbagen.2022.130215_bb0190 article-title: Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer publication-title: Sci. Rep. doi: 10.1038/s41598-019-57285-y – volume: 45 start-page: 804 year: 2021 ident: 10.1016/j.bbagen.2022.130215_bb0075 article-title: Proteomic analysis of radio-resistant breast cancer xenografts: increased TGF-β signaling and metabolism publication-title: Cell Biol. Int. doi: 10.1002/cbin.11525 – volume: 70 start-page: 10433 year: 2010 ident: 10.1016/j.bbagen.2022.130215_bb0055 article-title: Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-10-2638 – volume: 108 start-page: 7950 year: 2011 ident: 10.1016/j.bbagen.2022.130215_bb0005 article-title: Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.1102454108 – volume: 26 start-page: 1604 year: 2014 ident: 10.1016/j.bbagen.2022.130215_bb0035 article-title: TGF-β1-ROS-ATM-CREB signaling axis in macrophage mediated migration of human breast cancer MCF7 cells publication-title: Cell. Signal. doi: 10.1016/j.cellsig.2014.03.028 – volume: 8 start-page: 8704 year: 2018 ident: 10.1016/j.bbagen.2022.130215_bb0045 article-title: Snail knockdown reverses stemness and inhibits tumour growth in ovarian cancer publication-title: Sci. Rep. doi: 10.1038/s41598-018-27021-z – volume: 30 start-page: 1693 year: 2011 ident: 10.1016/j.bbagen.2022.130215_bb0175 article-title: Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells publication-title: Oncogene doi: 10.1038/onc.2010.546 – volume: 79 start-page: 4557 year: 2019 ident: 10.1016/j.bbagen.2022.130215_bb0010 article-title: The tumor microenvironment innately modulates cancer progression publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-18-3962 – volume: 2019 start-page: 7683817 year: 2019 ident: 10.1016/j.bbagen.2022.130215_bb0130 article-title: Genes involved in the transcriptional regulation of pluripotency are expressed in malignant tumors of the uterine cervix and can induce tumorigenic capacity in a nontumorigenic cell line publication-title: Stem Cells Int. doi: 10.1155/2019/7683817 – volume: 116 start-page: 148 year: 2019 ident: 10.1016/j.bbagen.2022.130215_bb0110 article-title: Toward understanding cancer stem cell heterogeneity in the tumor microenvironment publication-title: Proc. Natl. Acad. Sci. doi: 10.1073/pnas.1815345116 – volume: 32 start-page: 342 year: 2005 ident: 10.1016/j.bbagen.2022.130215_bb0195 article-title: Tumor necrosis factor-alpha induces transforming growth factor-beta1 expression in lung fibroblasts through the extracellular signal-regulated kinase pathway publication-title: Am. J. Respir. Cell Mol. Biol. doi: 10.1165/rcmb.2004-0288OC – volume: 2019 start-page: 3904645 year: 2019 ident: 10.1016/j.bbagen.2022.130215_bb0070 article-title: Aldehyde dehydrogenases: not just markers, but functional regulators of stem cells publication-title: Stem Cells Int. doi: 10.1155/2019/3904645 – volume: 2018 start-page: 1537 year: 1862 ident: 10.1016/j.bbagen.2022.130215_bb0020 article-title: Transforming growth factor-β modulates pancreatic cancer associated fibroblasts cell shape, stiffness and invasion publication-title: Biochim. Biophys. Acta Gen. Subj. – volume: 10 start-page: 253 year: 2016 ident: 10.1016/j.bbagen.2022.130215_bb0230 article-title: Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells publication-title: Mol. Oncol. doi: 10.1016/j.molonc.2015.10.002 – volume: 10 start-page: 1596 year: 2018 ident: 10.1016/j.bbagen.2022.130215_bb0115 article-title: Heterogeneity of human breast stem and progenitor cells as revealed by transcriptional profiling publication-title: Stem Cell Reports doi: 10.1016/j.stemcr.2018.03.001 – volume: 9 start-page: 837 year: 2019 ident: 10.1016/j.bbagen.2022.130215_bb0085 article-title: Cellular plasticity in cancer publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-19-0015 – volume: 116 start-page: 7353 year: 2019 ident: 10.1016/j.bbagen.2022.130215_bb0120 article-title: Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.1812876116 – volume: 16 year: 2019 ident: 10.1016/j.bbagen.2022.130215_bb0205 article-title: A possible role for epigenetic feedback regulation in the dynamics of the epithelial-mesenchymal transition (EMT) publication-title: Phys. Biol. doi: 10.1088/1478-3975/ab34df – volume: 352 start-page: 160 year: 2014 ident: 10.1016/j.bbagen.2022.130215_bb0030 article-title: Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma publication-title: Cancer Lett. doi: 10.1016/j.canlet.2014.05.008 – volume: 9 start-page: 24272 year: 2018 ident: 10.1016/j.bbagen.2022.130215_bb0095 article-title: Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer publication-title: Oncotarget doi: 10.18632/oncotarget.24917 – volume: 39 start-page: 279 year: 2022 ident: 10.1016/j.bbagen.2022.130215_bb0125 article-title: Interconnected high-dimensional landscapes of epithelial-mesenchymal plasticity and stemness in cancer publication-title: Clin. Exp. Metastasis doi: 10.1007/s10585-021-10139-2 – volume: 8 start-page: 99801 year: 2017 ident: 10.1016/j.bbagen.2022.130215_bb0025 article-title: Tumor-associated macrophages promote tumor metastasis via the TGF-β/SOX9 axis in non-small cell lung cancer publication-title: Oncotarget doi: 10.18632/oncotarget.21068 – volume: 6 start-page: 24606 year: 2016 ident: 10.1016/j.bbagen.2022.130215_bb0050 article-title: Twist-mediated epithelial-mesenchymal transition promotes breast tumor cell invasion via inhibition of hippo pathway publication-title: Sci. Rep. doi: 10.1038/srep24606 – volume: 3 start-page: 1055 year: 2012 ident: 10.1016/j.bbagen.2022.130215_bb0170 article-title: TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer publication-title: Nat. Commun. doi: 10.1038/ncomms2039 – volume: 7 start-page: 13856 year: 2017 ident: 10.1016/j.bbagen.2022.130215_bb0105 article-title: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis publication-title: Sci. Rep. doi: 10.1038/s41598-017-14364-2 – volume: 20 year: 2019 ident: 10.1016/j.bbagen.2022.130215_bb0145 article-title: TGF-β-mediated epithelial-mesenchymal transition and cancer metastasis publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms20112767 – volume: 105 start-page: 1079 year: 2013 ident: 10.1016/j.bbagen.2022.130215_bb0200 article-title: Coupled reversible and irreversible bistable switches underlying TGFβ-induced epithelial to mesenchymal transition publication-title: Biophys. J. doi: 10.1016/j.bpj.2013.07.011 – volume: 8 start-page: 33694 year: 2017 ident: 10.1016/j.bbagen.2022.130215_bb0210 article-title: AKR1B10 promotes breast cancer cell migration and invasion via activation of ERK signaling publication-title: Oncotarget doi: 10.18632/oncotarget.16624 – volume: 9 year: 2017 ident: 10.1016/j.bbagen.2022.130215_bb0240 article-title: Targeting TGF-β signaling for therapeutic gain publication-title: Cold Spring Harb. Perspect. Biol. doi: 10.1101/cshperspect.a022301 – volume: 40 start-page: 2558 year: 2018 ident: 10.1016/j.bbagen.2022.130215_bb0090 article-title: Tumor associated macrophages induce epithelial to mesenchymal transition via the EGFR/ERK1/2 pathway in head and neck squamous cell carcinoma publication-title: Oncol. Rep. – volume: 3 start-page: 1361 year: 2010 ident: 10.1016/j.bbagen.2022.130215_bb0225 article-title: The origins and implications of intratumor heterogeneity publication-title: Cancer Prev. Res. (Phila.) doi: 10.1158/1940-6207.CAPR-10-0234 – volume: 108 start-page: 1397 year: 2011 ident: 10.1016/j.bbagen.2022.130215_bb0160 article-title: Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.1018898108 – volume: 12 year: 2019 ident: 10.1016/j.bbagen.2022.130215_bb0185 article-title: Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition publication-title: Sci. Signal. doi: 10.1126/scisignal.aau8544 – volume: 13 start-page: 49 year: 2013 ident: 10.1016/j.bbagen.2022.130215_bb0135 article-title: Breast cancer stem cell enrichment and isolation by mammosphere culture and its potential diagnostic applications publication-title: Expert. Rev. Mol. Diagn. doi: 10.1586/erm.12.117 – volume: 6 start-page: 29479 year: 2016 ident: 10.1016/j.bbagen.2022.130215_bb0180 article-title: Conditional ablation of TGF-β signaling inhibits tumor progression and invasion in an induced mouse bladder cancer model publication-title: Sci. Rep. doi: 10.1038/srep29479 – volume: 194 start-page: 23 year: 1976 ident: 10.1016/j.bbagen.2022.130215_bb0220 article-title: The clonal evolution of tumor cell populations publication-title: Science doi: 10.1126/science.959840 – volume: 27 start-page: 121 year: 2021 ident: 10.1016/j.bbagen.2022.130215_bb0100 article-title: Macrophages and cancer stem cells: a malevolent alliance publication-title: Mol. Med. doi: 10.1186/s10020-021-00383-3 – volume: 2016 start-page: 1740936 year: 2016 ident: 10.1016/j.bbagen.2022.130215_bb0235 article-title: Cancer stem cell quiescence and plasticity as major challenges in cancer therapy publication-title: Stem Cells Int. doi: 10.1155/2016/1740936 – volume: 6 start-page: 603 year: 2004 ident: 10.1016/j.bbagen.2022.130215_bb0080 article-title: Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro publication-title: Neoplasia doi: 10.1593/neo.04241 |
SSID | ssj0000595 |
Score | 2.4247003 |
Snippet | Breast cancer is a heterogenous disease composed of multiple clonal populations and the mechanism by which the tumor microenvironment induces cancer stem cell... |
SourceID | proquest crossref |
SourceType | Aggregation Database Enrichment Source Index Database |
StartPage | 130215 |
SubjectTerms | breast neoplasms epithelium hybrids interleukin-6 macrophages neutralization phosphorylation plasticity stem cells vimentin |
Title | Macrophage induced ERK-TGF-β1 signaling in MCF7 breast cancer cells result in reversible cancer stem cell plasticity and epithelial mesenchymal transition |
URI | https://www.proquest.com/docview/2696859789 https://www.proquest.com/docview/2718349765 |
Volume | 1866 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtNAEF6FIgQXBAXUUkCLRE-WI6__c6RRQgVNkcCRcrN2N7bsEpwqsQ_pgXfgzFvwIDwTM7v-SdQKChcn2UycxPN5d2b2mxlC3jAmwYpnnhlyaZkuE8wUfpqagg_gQTi2Z2Ny8uTcP52672ferNf7vsVaqkrRl1c35pX8j1ZhDPSKWbL_oNn2pDAAz0G_cAQNw_FWOp5wbMCVIe0GXOsKt_JHnz6Y0buxeTwcHZ_YzEB-Bl_UiSuT4TgwBNLQS2R7yWRlYOAedw7W1aLUuS2Kp4H5VLUEVnpWYthxGqs6o92O4fbkEvM5FrnKP1nDdck2XxV1HVa_vNV3s2GcL2WWY20CIykNkS91SIVjMQ_eb6pfG-tKYGBoa4cJ_peydFf5pl1BPme8-KKZ4ScZB18gryO4dfgCPF_Whi_0jBsGMCVbVl0P-4axdprW7VkaQLKtaRd3X3VW6LUVQQcnLvpCgCAWvLXtfie-W4D7_GM8np6dxdFoFt0hd-0gUDv__W8dawisUWTFtr-wycZUlMHr37Fr7ewu9sqCiR6Rh7XrQd9qHD0mvaTYJ_d0M9LNPrk_bHr_PSE_OmTRGlm0Qdavn4y2qIJ3KaKKalRRjRmqUEU1qlCkQ1UjgahSYrRDFQVU0Q5VdAtVtEPVUzIdj6LhqVm38TCl7QalKUPBZOoLYcmBH_gevPIH6Hb7YJu6cwn-necKMNPn2DRahKnFw5QlYPqmjj_njvOM7BXLIjkgNOVgvgrwSBjHGrjz0LUt7qeJK8MgtaR_SJzmcseyrnGPrVYWcUNmvIi1kmJUUqyVdEjM9lOXusbLX-RfN5qMQS94rXiRLKt1bGOpKXDRw8EfZMAadFzwArzntzjPEXnQ3TUvyF65qpKXYAaX4pUC5m9O8bfn |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Macrophage+induced+ERK-TGF-%CE%B21+signaling+in+MCF7+breast+cancer+cells+result+in+reversible+cancer+stem+cell+plasticity+and+epithelial+mesenchymal+transition&rft.jtitle=Biochimica+et+biophysica+acta.+General+subjects&rft.au=Kundu%2C+Priya&rft.au=Shankar%2C+Bhavani+S&rft.date=2022-11-01&rft.issn=1872-8006&rft.eissn=1872-8006&rft.volume=1866&rft.issue=11&rft.spage=130215&rft_id=info:doi/10.1016%2Fj.bbagen.2022.130215&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon |